Please use this identifier to cite or link to this item: http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11432
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHamoda, T.-
dc.contributor.authorShah, R.-
dc.contributor.authorMostafa, T.-
dc.contributor.authorGermar-Michael, P.-
dc.contributor.authorAtmoko, W.-
dc.contributor.authorBalagobi, B.-
dc.date.accessioned2025-07-24T06:15:13Z-
dc.date.available2025-07-24T06:15:13Z-
dc.date.issued2025-
dc.identifier.urihttp://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11432-
dc.description.abstractPurpose: Non-obstructive azoospermia (NOA), defined as the absence of sperm in the ejaculate due to testicular failure, is observed in 5% to 15% of infertile men and accounts for two-thirds of azoospermia cases. The management of NOA is marked by significant controversy and global variation in diagnostic and therapeutic approaches, highlighting the crucial need for well-designed and standardized clinical practice guidelines. We present comprehensive graded clinical practice recommendations and statements for diagnosing and treating NOA, aiming to establish standardized strategies that can glob- ally help guide practitioners in their practice. Materials and Methods: A comprehensive literature review was conducted to gather evidence on the epidemiological, di- agnostic, and therapeutic aspects of NOA. The Global Andrology Forum (GAF) recommendations were developed through the collaboration of a global panel of experts using the Delphi method and surveys to achieve consensus. Statements were graded according to the Oxford Centre for Evidence-Based Medicine “GRADE” classification as either “Strong” or “Weak.” Statements receiving at least 80% expert consensus were graded as “Strong,” while others were categorized as “Weak.” Results: The GAF has formulated a total of 49 recommendations and statements on the diagnosis and treatment of NOA, in- cluding 21 for diagnosis and 28 for treatment. The recommendations and statements were evaluated and graded by a panel of 48 GAF experts from 25 countries worldwide. The majority of experts (60.5%) had more than 10 years of clinical experi- ence in managing NOA. Conclusions: The GAF guidelines address discrepancies in NOA management across diverse clinical settings and provide comprehensive graded recommendations to guide clinicians in its diagnosis and treatment. Developed and graded by a large worldwide panel of experts, the current guidelines present simplified, high-standard strategies that can be seamlessly inte- grated into the daily global practice, offering practitioners a clear framework for managing NOA.en_US
dc.language.isoenen_US
dc.publisherKorean Society for Sexual Medicine and Andrologyen_US
dc.subjectAzoospermiaen_US
dc.subjectGuidelineen_US
dc.subjectInfertilityen_US
dc.subjectPregnancyen_US
dc.subjectSemenen_US
dc.subjectSperm retrievalen_US
dc.titleGlobal Andrology Forum (GAF) Clinical Guidelines on the Management of Non-obstructive Azoospermia: Bridging the Gap between Controversy and Consensusen_US
dc.typeArticleen_US
Appears in Collections:Surgery

Files in This Item:
File Description SizeFormat 
Global Andrology Forum (GAF) Clinical.pdf873.71 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.